This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
Value or Growth: Which ETFs to Play Ahead?
by Sanghamitra Saha
If things turn right on the vaccine front in the coming days, one can surely expect a rise in economic activity and bond yields, and a rally in value stocks.
ETF Strategies to Gain From US Market Optimism
by Sweta Jaiswal, FRM
Let's look at some ETF strategies to help investors gain from the optimism surrounding the coronavirus vaccine development as the outbreak continues to aggravate.
ETF Strategies to Gain From US Economic Data Optimism
by Sweta Jaiswal, FRM
Let's look at some ETF strategies to help investors gain from the upbeat U.S. economic data amid the coronavirus crisis.
Factor & Smart Beta ETFs: What You Should Know
by Neena Mishra
We discuss factor investing and Q4 market outlook.
Here's Why it is the Right Time to Invest in Momentum ETFs
by Sweta Jaiswal, FRM
Here we highlight the reasons that make momentum ETFs lucrative investment picks now.
ETF Strategies to Gain From Vaccine Progress, M&A Deals
by Sweta Jaiswal, FRM
ETF Strategies to Gain From Vaccine Progress, M&A Activities
Bet on These Momentum & High-Beta ETFs on Treatment Hopes
by Sanghamitra Saha
Wall Street has regained momentum this week hitting new highs on vaccine hopes.
U.S. Momentum ETF (MTUM) Hits New 52-Week High
by Sweta Killa
This U.S. momentum ETF hits a new 52-week high. Are more gains in store for this ETF?
ETF Strategies to Play Market Optimism Amid Coronavirus Crisis
by Sweta Jaiswal, FRM
Here we look at some ETF strategies for investors to gain from the current bullish sentiments in the market.
Here's Why it Makes Sense to Invest in Momentum ETFs Now
by Sweta Jaiswal, FRM
Here we discuss whether it will be wise to invest in momentum ETFs now as the U.S. manufacturing is showing signs of recovery along with improvements in the job market.